- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00612833
A Randomized Controlled Trial of Three Vasectomy Techniques
This study will be a randomized, controlled multicenter trial, conducted jointly by the Indian Council of Medical Research, New Delhi and Family Health International, which will compare three vasectomy occlusion techniques, all using the no-scalpel vasectomy (NSV) approach to isolation of the vas:
- ligation and excision of about 1 cm of the vas, with fascial interposition;
- intraluminal thermal cautery with excision of about 1 cm of the vas;
- intraluminal thermal cautery with excision of about 1 cm of the vas combined with fascial interposition.
A total of 1500 healthy, sexually active men at least 21 years old who have chosen vasectomy as a means of contraception will be recruited at four to six study sites in India. The success of the vasectomy procedure will be determined based on semen analysis results. All men should have semen analyses at 8 and 12 weeks post-vasectomy. All men will be asked to attend a final visit at 12 months.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study will be a randomized, controlled multicenter trial, conducted jointly by the Indian Council of Medical Research, New Delhi and Family Health International, which will compare three vasectomy occlusion techniques, all using the no-scalpel vasectomy (NSV) approach to isolation of the vas:
- ligation and excision of about 1 cm of the vas, with fascial interposition;
- intraluminal thermal cautery with excision of about 1 cm of the vas; and,
- intraluminal thermal cautery with excision of about 1 cm of the vas combined with fascial interposition.
A total of 1500 healthy, sexually active men at least 21 years old who have chosen vasectomy as a means of contraception will be recruited at four to six study sites in India. The success of the vasectomy procedure will be determined based on semen analysis results. All men should have semen analyses at 8 and 12 weeks post-vasectomy. All men will be asked to attend a final visit at 12 months.
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Delhi
-
New Delhi, Delhi, India, 110 002
- Maulana Azad Medical College
-
New Delhi, Delhi, India, 110 054
- St. Stephens Hospital
-
-
Haryana
-
Rohtak, Haryana, India, 124 001
- Post Graduate Institute of Medical Sciences
-
-
Punjab
-
Amritsar, Punjab, India, 143 001
- Civil Hospital,
-
-
Sikkim
-
Gangtok, Sikkim, India, 737 101
- E. S.T.N.M. Hospital, Gangtok
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Freely consent to participate in the study and sign an informed consent form
- Be at least 21 years old
- The couple should have at least one living child greater than one year of age
- With his partner be willing to use an alternate method of contraception until success is confirmed
- Be willing to return for follow-up visits at 1, 8, 12 and 52 weeks post-vasectomy, and at 16, 20 and 24 weeks if needed
- Be willing to submit semen samples collected by masturbation in the clinic according to the study follow-up schedule
- Be able to understand the procedures and study requirements
Exclusion Criteria:
- Has a condition that in the opinion of the investigator permanently or temporarily contraindicates participation in the study, e.g., depression or poorly-controlled diabetes
- History of surgery involving the vas or testes (including previous vasectomy)
- Previous injury or significant abnormality of the scrotum
- Clinical evidence of an acute sexually transmitted infection; however a man may be admitted to the study after resolution of the acute condition.
- Local genital infections such as balanitis, scrotal skin infection, epididymitis, or orchitis, but a man may be admitted after resolution of an acute infection
- History of coagulation or other bleeding disorders
- Large varicocele, hydrocele, filariasis or elephantiasis of scrotum, or intrascrotal mass
- Acute systemic infection (including gastroenteritis), but a man may be admitted after resolution of the condition
- Currently taking or planning to take any type of systemic medication which could affect sperm count (e.g. anabolic steroids)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: cautery excision with fascial interposition
Contraception using cautery and excision with fascial interposition
|
Cautery and excision with fascial interposition Cautery and excision without fascial interposition Ligation and excision with fascial interposition
|
Active Comparator: B
Cautery and excision without fascial interposition
|
Cautery and excision with fascial interposition Cautery and excision without fascial interposition Ligation and excision with fascial interposition
|
Active Comparator: C
Ligation and excision with fascial interposition
|
Cautery and excision with fascial interposition Cautery and excision without fascial interposition Ligation and excision with fascial interposition
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Sperm concentration in semen
Time Frame: 12 weeks
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Safety
Time Frame: up to 12 months
|
up to 12 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Chander Shekhar, MD, ICMR
- Principal Investigator: David C. Sokal, MD, FHI 360
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Contraception
-
Virginia Commonwealth UniversityCompletedPregnancy Related | Contraception | Contraception Behavior | Contraception Use
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedFemale Contraception | Contraception
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Medical University of South CarolinaSociety of Family PlanningCompletedContraception | Contraception BehaviorUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedFemale Contraception | ContraceptionUnited States, Israel
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedFemale Contraception | Contraception
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedFemale Contraception | Contraception
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
University of California, San FranciscoAgency for Healthcare Research and Quality (AHRQ); Essential Access HealthNot yet recruitingContraception | Contraception Behavior | Reproductive BehaviorUnited States
Clinical Trials on Vasectomy occlusion techniques
-
University of NebraskaWithdrawnVirtual Reality | VasectomyUnited States
-
Ministry of Science and Technology of the People´s...Beijing Municipal Science & Technology CommissionCompletedIntracranial Arteriovenous MalformationsChina
-
liuxingjuBeijing Municipal Science & Technology CommissionUnknownIntracranial Aneurysm | Atheroscleroses, Cerebral | Cerebrovascular StenosisChina
-
liuxingjuBeijing Municipal Science & Technology CommissionUnknownIntracranial AneurysmChina
-
Jaeb Center for Health ResearchNational Eye Institute (NEI); Pediatric Eye Disease Investigator GroupCompleted
-
University of OttawaUnknownConcussion Post Syndrome
-
Odense University HospitalUnknownPostoperative HemorrhageDenmark
-
National Institute of Diabetes and Digestive and...RecruitingHealthy | Obesity | Diabetes | Atherosclerosis | Healthy VolunteersUnited States
-
Sheffield Teaching Hospitals NHS Foundation TrustCompleted
-
Universitat Politècnica de CatalunyaParc Sanitari Sant Joan de Déu; Hospital Mutua de TerrassaCompletedAmblyopia | Anisometropic Amblyopia | Strabismic Amblyopia | Amblyopia Occlusion | Unilateral AmblyopiaSpain